San Francisco Bay Area HIV Clinical Trials Unit (CTU) led by top HIV prevention and treatment experts
Official title: San Francisco Bay Clinical Trials Unit (CTU)
Funded at Public Health Foundation Enterprises · NIH-11617649 · Data updated 2026-11-12
A large HIV clinical trials program in the San Francisco Bay Area aims to speed prevention and treatment research for people at risk or living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Public Health Foundation Enterprises NIH-funded |
| Lab location | 1 site (City of Industry, United States) |
| Project start | March 2, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,451,256 |
| NIH project number | 3UM1AI069496-20S2 |
| Project ID | NIH-11617649 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults in the San Francisco Bay Area at risk for HIV or living with HIV who are eligible for network clinical trials.
✕Less likely to help
Patients not eligible for specific trials or not residing in the Bay Area may not directly benefit.
What this research studies
This grant supports the San Francisco Bay Area CTU, affiliated with ACTG, HPTN, and HVTN, to accelerate HIV prevention and treatment studies while engaging local communities. It focuses on efficient, protocol-adherent clinical trials and the development of future leaders in HIV science. The initiative brings together two experienced site leaders and a team with a strong track record in enrollment, retention, and community engagement. The CTU plans to advance science at the intersection of prevention and treatment and to train the next generation of researchers.
Why it matters
Potential benefit: If successful, patients could benefit from faster access to effective HIV prevention and treatment options discovered through these trials.
How similar studies have gone: Previous networks have demonstrated strong enrollment and adherence in HIV trials, supporting the potential for success in this initiative.
Where this research is happening
-
Public Health Foundation Enterprises
City of Industry, United States Active
Researchers
- Principal investigator: Buchbinder, Susan — Public Health Foundation Enterprises
- Study coordinator: Buchbinder, Susan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.